Peroxisome Proliferator-Activated Receptor Gene Knockout Promotes Podocyte Injury in Diabetic Mice

Rui Yan1, Ye Zhang1, Yuxing Yang2

  • 1Department of Nephrology Affiliated Hospital of Guizhou Medical University, Guiyang, 550004 Guizhou, China.

Abstract

Insights

Loss of peroxisome proliferator-activated receptor gamma (PPARγ) worsens kidney damage in diabetic mice, promoting fibrosis. Increasing PPARγ may treat diabetic nephropathy by protecting podocytes.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Diabetology

Background:

  • Diabetic nephropathy is a major complication of diabetes mellitus.
  • Podocyte injury is a key event in the pathogenesis of diabetic nephropathy.
  • Peroxisome proliferator-activated receptor gamma (PPARγ) plays a role in regulating renal function.

Purpose of the Study:

  • To investigate the role of PPARγ in diabetic kidney disease.
  • To determine the effect of PPARγ knockout on podocyte damage and renal fibrosis in diabetic mice.

Main Methods:

  • Established a diabetic mouse model using wild-type and PPARγ gene knockout mice.
  • Administered HE and Masson staining, transmission electron microscopy, immunohistochemistry, Western blot, and qRT-PCR to analyze renal tissues.
  • Assessed protein and mRNA expressions of PPARγ, podocin, nephrin, collagen IV, and fibronectin.

Main Results:

  • Diabetic mice showed decreased PPARγ, podocin, and nephrin expression, and increased collagen IV and fibronectin.
  • PPARγ knockout exacerbated these changes, indicating a protective role for PPARγ.
  • Non-diabetic PPARγ knockout mice showed reduced PPARγ but no significant changes in other markers.

Conclusions:

  • Loss of PPARγ aggravates podocyte damage and promotes renal fibrosis in diabetic mice.
  • Increasing PPARγ expression may be a therapeutic strategy for diabetic nephropathy.
  • PPARγ is crucial for protecting podocytes and preventing renal fibrosis in diabetes.